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The Journal of Immunology
Salmonella enterica Serovar Typhimurium Travels
to Mesenteric Lymph Nodes Both with Host Cells
and Autonomously
Alberto Bravo-Blas,* Lotta Utriainen,*,1 Slater L. Clay,* Verena Ka¨stele,*
Vuk Cerovic,*,2 Adam F. Cunningham,† Ian R. Henderson,‡ Daniel M. Wall,*
and Simon W. F. Milling*
Salmonella infection is a globally important cause of gastroenteritis and systemic disease and is a useful tool to study immune
responses in the intestine. Although mechanisms leading to immune responses against Salmonella have been extensively studied,
questions remain about how bacteria travel from the intestinal mucosa to the mesenteric lymph nodes (MLN), a key site for Ag
presentation. In this study, we used a mouse model of infection with Salmonella enterica serovar Typhimurium (STM) to identify
changes in intestinal immune cells induced during early infection. We then used fluorescently labeled STM to identify interactions
with immune cells from the site of infection through migration in lymph to the MLN. We show that viable STM can be carried in
the lymph by any subset of migrating dendritic cells but not by macrophages. Moreover, approximately half of the STM in lymph
are not associated with cells at all and travel autonomously. Within the MLN, STM associates with dendritic cells and B cells but
predominantly with MLN-resident macrophages. In conclusion, we describe the routes used by STM to spread systemically in the
period immediately postinfection. This deeper understanding of the infection process could open new avenues for controlling
it. The Journal of Immunology, 2019, 202: 260–267.
S
almonella enterica species present a serious public health
burden, causing gastroenteritis and systemic infection in
humans and domestic animals. S. enterica serovars Typhi
and Paratyphi cause systemic fever in humans, with over 20
million cases and 200,000 deaths annually (1), including virulent
S. enterica serovar Typhimurium (STM) strains that have emerged
in sub-Saharan Africa with 20–25% mortality (2). STM infects a
wide range of animals and is one of the most common serotypes
associated with human infections. Experimentally, many genetic
variants of this strain are available, including constructs expressing
a wide range of reporter genes. These STM strains are used to in-
duce acute or persistent infections with localized or systemic dis-
ease (3, 4) and have been used to identify molecular determinants
controlling the infective process.
Following oral ingestion, STM can cross the intestinal epi-
thelium either through M cells, via transepithelial sampling by
mononuclear phagocytes, or by transcytosis of epithelial cells (5).
Uptake of Ag, cell migration, and Ag presentation are critical
steps in controlling systemic dissemination of the pathogen and
induction of adaptive immunity (6). However, the cellular mech-
anisms used by this intestinal pathogen to move from the site of
infection to the mesenteric lymph nodes (MLN) remain ill defined.
In this study, we use two previously characterized oral infection
protocols, with commonly used variants of STM, to understand
this important immunological process.
Using the accurate definitions of murine intestinal mononuclear
phagocytes that have now been developed (7, 8), we aimed to
investigate which APCs are involved in the early events after oral
STM infection and how the bacteria travel to the MLN, a critical
tissue that limits systemic spread of STM (9). In this study, we find
that although few cellular changes occur in the intestine in the
days immediately following STM infection, bacteria can be de-
tected migrating in cell-associated form and autonomously from
the intestine to the MLN in intestine-draining lymph. The majority
of the migrating bacteria are captured by macrophages in the
MLN. Collectively, our results provide a detailed description of
how Salmonella affects the intestine after the initial infection and
uses the lymph to migrate to the MLN. Understanding this movement
of STM to the MLN enables elucidation of the role of the various
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populations of APCs in controlling infection and initiating adap-
tive immune responses to intestinal bacteria.
Materials and Methods
Mice
C57BL/6 male mice were purchased from Envigo (Bicester, U.K.) and main-
tained in individually ventilated cages. CX3CR1+/GFP reporter mice (originally
a gift from Steffen Jung) were bred and maintained under specific pathogen-
free conditions at the Central Research Facility, University of Glasgow, U.K.
Ethics statement
All procedures were approved by the AnimalWelfare Ethical Review Board
at the University of Glasgow. This committee approved the project license,
which was also approved by the U.K. Home Office. The project license has
the number 60/4500. The license complies with the Animals (Scientific
Procedures) Act 1986. The Animals (Scientific Procedures) Act has been
revised to transpose European Directive 2010/63/EU on the protection of
animals used for scientific purposes.
Reagents
Cells were cultured in RPMI 1640, supplemented with 100 Uml21 penicillin,
100 mg ml21 streptomycin, 2 mM L-glutamine, 5% FCS (Invitrogen,
Waltham, MA), and 50 mM 2-ME (Sigma-Aldrich, St. Louis, MO).
Abs
Fluorochrome-conjugated mAb to mouse Ags CD11c on PE/Cy7, CD103
on APC, CD11b and MHC class II (MHC II) on AF700, MHC II and CD45
on V450, B220 on BV510, CD11b, streptavidin on BV605, and CD3 and
CD64 on BV711 were from BioLegend (San Diego, CA).
Surgical procedures
Animals were maintained under inhalation anesthesia with isoflurane (Abbott
Labs, Abbott Park, IL).MLNx and thoracic duct cannulations were performed
according to previously established protocols (10, 11). Briefly, mesenteric
lymphadenectomy was performed on six-wk-old C57/BL6 male mice by
laparotomy and blunt dissection. Six weeks later, mCherry STM-infected
mice were fed 0.3 ml of olive oil to visualize the lymphatics, and the thoracic
duct was cannulated by the insertion of a polyurethane cannula (2Fr; Linton
Instrumentation, Diss, U.K.). Lymph was collected in PBS with 20 U ml21
of heparin sodium (Wockhardt UK, Wrexham, U.K.) on ice for up to 16 h.
Bacterial culture
All STM variants used were derived from thewild-type STM strain SL1344.
Attenuated strain DinvG STM was kindly provided by Adam Cunningham
(University of Birmingham), and DaroA pET-tac mCherry STM was kindly
provided by Ian Henderson (University of Birmingham). For infection, a
single bacterial colony was grown in Luria–Bertani (LB) broth at 37˚C and
200 rpm before being back-diluted 1:10 in fresh LB broth and cultured in a
static incubator overnight at 37˚C.
Infection model
Micewere pretreated with one of two of the following antibiotic regimens: a
mixture of vancomycin (0.5 mg ml21), neomycin (1 mg ml21), metroni-
dazole (1 mg ml21), and ampicillin (1 mg ml21) added to drinking water
for 14 d prior to infection with DinvG and DaroA mutants, or a single dose
of streptomycin (20 mg) administered by oral gavage 24 h prior to in-
fection with SL1344 (12). Mice infected by oral gavage with DinvG STM
received 1 3 108 CFU, whereas pET-tac mCherry STM and SL1344 STM
were adjusted to 5 3 107 CFU.
Cell isolation
Small intestine (SI) and colons were washed in HBSS with 2% FCS, following
Peyer patch excision. Intestines were opened longitudinally and cut into 0.5 cm
segments and incubated in HBSS with 2 mM EDTA (Sigma-Aldrich) at 37˚C,
shaking for 20 min to remove the epithelial cell layer and mucus. The SI lamina
propria (LP) was digested with 1 mg ml21 collagenase VIII (Sigma-Aldrich) for
20 min, whereas colonic LP was digested with 0.85 mg ml21 of collagenase
V (Sigma-Aldrich), 1.25 mg ml21 collagenase D (Roche, Penzberg, Germany),
1 mg ml21 dispase (Life Technologies, Paisley, U.K.), and 30 mg ml21 DNase
(Roche) for 40 min. Cells were then passed through a 40-mm cell strainer
(VWR, Radnor, PA) and stained for flow cytometry. LNs were separated and
incubated with 0.4 Wunsch units ml21 Liberase TM and 50 mg ml21 of DNase
(Roche) for 45 min at 37˚C while shaking. Single-cell suspensions were
passed through a 40-mm cell strainer and stained for flow cytometry. Lymph
from thoracic duct cannulation was filtered through a 100-mm mesh, washed
with HBSS EDTA, and spun at 4003 g for 5 min. Next, the cellular pellet was
separated from the supernatant, and this was spun once more, this time at
6500 3 g for 5 min to pellet and collect cell-independent bacteria.
Flow cytometry
Cell surface staining was performed in PBS with 2% FCS and 2 mM EDTA
for 30 min on ice. To determine cell viability, 20 ml of 7AAD (BioLegend)
was added to samples just before analysis, or 1 ml of fixable viability dye
eFluor 780 (eBioscience) was added to samples in PBS for 30 min at 4˚C
before staining with Abs. Samples were acquired on an LSR II or a
FACSAria III (BD Biosciences).
Bacterial recovery
Spleen, SI, colon,MLN (for non-MLNx animals), and inguinal lymph nodes
(ILNs) were harvested and weighed. Next, organs were homogenized using
a stomacher, and bacteria present in tissues were quantified by plating of
serial dilutions on LB agar. LB agar was supplemented with streptomycin
50 mg ml21 for SL1344 and ampicillin 100 mg ml21 for the experiments
using mCherry STM.
Statistical analysis
Data were analyzed using one- or two-way ANOVA and unpaired Student t
test. The p values , 0.05 were considered significant. Statistical analysis
was performed using Prism 6 (GraphPad, San Diego, CA).
Results
MLN dendritic cell numbers remain stable after antibiotic
administration or STM infection
We and others have previously shown that the dendritic cells
(DCs) that migrate constitutively from the intestinal mucosa are
known to transport Ag to the MLN (13–17). Migratory DCs are
also able to transport Salmonella from the intestine, as dem-
onstrated using Salmonella strains SL1344 and DaroA, an at-
tenuated, auxotrophic SL1344 derivative (9). Interestingly,
when an invasion-deficient attenuated STM strain (DinvA) was
used, migrating macrophage-like cells were reported to be re-
sponsible for transporting STM from the intestine. Thus, to
understand the effects of STM infection on migration, we first
assessed the effect of STM infection on migratory cells in the
MLN. To achieve bacterial colonization of the intestinal mucosa,
animals were pretreated for 10 d with an antibiotic mixture,
comprising vancomycin, neomycin, metronidazole, and ampicil-
lin, or normal drinking water (negative control), which has pre-
viously been used to enable STM infection in experiments where
macrophage-like cells were reported to migrate from the intestine
(18, 19). Mice were orally infected with 1 3 108 CFU of atten-
uated DinvG STM. MLN were harvested 48 h postinfection (hpi),
digested into single-cell suspensions, and analyzed by flow cytometry.
The four populations of CD642B2202CD11c+MHC IIhi migratory
DCs, as previously described (20), were identified by their expression
of CD103 and CD11b (CD103+CD11b2, CD1032CD11b+,
CD103+CD11b+ double positive, or CD1032CD11b2 double nega-
tive) (Fig. 1A). No significant changes were observed in the pro-
portions of these populations after antibiotic pretreatment, STM
infection, or both (Fig. 1B). Similarly, no significant changes were
observed in the frequency of migratory DCs and macrophage-like
cells in the MLN or in the total number of migratory MLN DCs
(Fig. 1C and data not shown). Thus, neither antibiotic pretreat-
ment, nor STM infection, altered the frequency or number of any
of the migratory DC populations in the MLN.
STM infection induces increase in number of macrophages in
the SI but not colonic LP
At early time points postinfection, STM typically infects the SI by
invasion of the M cells located in the Peyer patches (21). After
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antibiotic treatment, STM also colonize the cecum and colon
(12). To understand the effects of STM infection on intestinal
macrophage and DCs populations, we assessed their numbers in
the SI and colon postinfection. We again used DinvG STM so that
we could compare our results with the previous (18). Mice were
orally infected or given PBS after 2 wk pretreatment with the
antibiotic mixture. This was followed by SI and colonic LP har-
vest at 48 hpi, followed by digestion into single-cell suspensions
and analysis by flow cytometry. Mononuclear phagocytes were
gated as live CD45+MHC II+CD11c+B2202 cells, following which
macrophages were identified by their expression of CD64. Similar to
our MLN data, the frequency of total LP DCs (Fig. 2A) and the
proportion of each of the DC subsets in the SI LP remained un-
altered following STM infection and/or pretreatment with the
antibiotic mixture (Fig. 2B). There was a small increase in the
frequency of CD64+ macrophages in the SI LP of mice 48 hpi with
STM following antibiotic mixture pretreatment compared with
those administered only antibiotics or STM (Fig. 2A). Interest-
ingly, this increase was not observed in the colonic LP, where no
significant changes in the frequencies of CX3CR1int or CX3CR1hi
populations were observed (Supplemental Fig. 1). These data in-
dicate that the numbers of DCs in the intestinal LP and the MLN
are not altered following treatment with the antibiotic mixture
and/or STM infection, whereas the frequency of CD64+ macro-
phages increased to a small but significant degree in the SI LP
but not in the colonic LP after a combination of both antibiotic
pretreatment and STM infection.
CX3CR1hi cells do not migrate in lymph after STM infection
Data from the MLN and intestine reveal only subtle changes in
mononuclear phagocyte numbers induced by STM infection and
antibiotic treatment. Therefore, to investigate whether STM in-
fection affected cells migrating from the intestine to the MLN via
lymphatics, we analyzed lymph cells directly obtained from the
thoracic duct of lymphadenectomized (referred to as MLNx) mice.
FIGURE 1. MLN DC populations are not altered by STM infection. (A)
Migratory DCs (CD45+CD642B2202MHC IIhiCD11c+) from MLN of STM-
infected or -uninfected mice (left panels) were categorized into four subsets based
on CD11b and CD103 expression (CD103+CD11b2, CD1032CD11b+, double
positive or double negative, right panels). Mice either received an antibiotic mixture
alone (Abx) followed by 1 3 108 DinvG STM, STM alone, or a combination
of both. The frequency of each DC subset (B) and the numbers and frequencies
of migratory DCs were calculated in each condition (C) (n = 4–6 per group,
data representative of three independent experiments). Error bars represent SD.
FIGURE 2. Antibiotics (Abx) and STM infection increase macrophage
frequency in SI. Mice were pretreated with Abx mixture followed by oral
infection with 1 3 108 DinvG STM or gavaged with PBS. Forty-eight hpi,
small intestines were harvested, and DC and macrophage populations were
analyzed by flow cytometry. (A) Macrophages were identified from DCs by
CD64 expression (left panel). SI LP was analyzed for total DC and mac-
rophage frequencies and the frequencies of each of the DC subsets (B).
n = 4–8 mice per group, representative of three independent experiments.
Error bars represent SD. (A) Right panel, *p , 0.05, two-way ANOVA
multiple comparisons.
262 SALMONELLA TYPHIMURIUM MIGRATION IN LYMPH
 by guest on M
arch 12, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
Normally, DCs migrating from the intestine complete their life
cycle by performing their functions and ultimately dying in the
MLN, hence the efferent lymph vessels are largely devoid of DCs.
Thus, using previously developed techniques from our laboratory,
MLN are surgically removed. Animals make a full recovery over a
period of at least 6 wk, which allows reanastomosis of lymphatics
and subsequent collection of “pseudo-afferent lymph” via can-
nulation of the thoracic duct (15). Following cannulation, animals
recover from surgery and are returned to their cages; lymph is then
collected for up to 24 h. Cannulation of CX3CR1+/GFP MLNx mice
not only allowed us to directly assess lymph-migrating cells but also
to easily identify CX3CR1hi mononuclear phagocytes, identified as
macrophages (22), even at low numbers. MLNx CX3CR1+/GFP mice
were infected with the DinvG STM after pretreatment with the
antibiotic mixture used above (18). At 48 hpi, thoracic duct can-
nulation was performed and lymph collected. The SI was also
harvested, processed, and analyzed for comparison. SI mononu-
clear phagocytes were identified as live MHC II+CD11c+ cells,
and macrophages were differentiated from DCs by their CD64
expression (Fig. 3A, left plot). Intestinal DCs and macrophages in
the CX3CR1+/GFP mice expressed different levels of CX3CR1-GFP,
which we describe as CX3CR1lo, CX3CR1int, or CX3CR1hi (Fig. 3A,
central and right panels, Fig. 3B). Our results show that, in our
hands, only a residual fraction (,2.5%) of intestinal DCs were
CX3CR1hi, whereas .90% of CD64+ macrophages expressed high
levels of CX3CR1-GFP (Fig. 3A, 3B). Moreover, of the lymph cells
harvested from the thoracic duct of MLNx mice postinfection, none
were CD64+, and fewer than 0.2% fell within the CX3CR1hi gate
(Fig. 3C middle and data not shown). Almost a quarter (23%) of
lymph DCs were CX3CR1int (Fig. 3C, 3D). To confirm that no
CX3CR1hi cells from lymph had been excluded as a result of the
flow cytometric gating on CD11c+MHC IIhi cells, total live cells in
the lymph were also analyzed. These results mirrored the results
from pregated lymph (Fig. 3C, right panel). Thus, although .90%
of macrophages in the SI LP express high levels of CX3CR1,
these cells are absent from lymph after STM infection. Contrary
to previously published data using a similar strain of STM and
similar antibiotic pretreatment (18), after STM infection, the
CD11c+ MHC IIhi lymph migratory cells are DCs (CX3CR1int or
CX3CR1lo) rather than CD64+CX3CR1hi macrophages.
All DC subsets can carry fluorescent STM in lymph
Having established that macrophage-like cells do not migrate in
lymph after STM infection, we aimed to understand how STM
migrate from the intestine to the MLN. To achieve this aim, we
switched to the commonly used auxotrophic SL1344-derived
DaroA mutant (23). Use of this auxotrophic strain enables anal-
ysis of STM uptake and transport independent of confounding
factors that occur if extensive bacterial replication can occur. To
positively identify the cells carrying STM in lymph in the initial
period postinfection, we used an mCherry-expressing strain of
DaroA STM. This allowed us to analyze cells associated with
fluorescent bacteria by flow cytometry. After a 2-wk antibiotic
pretreatment, MLNx mice were infected with mCherry STM, and
lymph was collected 48 hpi for analysis. We expected that only
MHC IIhi DCs would be associated with an mCherry-positive
signal. However, our results revealed mCherry+ cells with at
least two different levels of MHC II expression. These data in-
dicate that multiple lymph-migrating cell types could be associ-
ated with STM (Fig. 4A). Because it is known that DCs express
high levels of MHC II, including when they travel in the lymph
(8, 24), we first analyzed mCherry+ and mCherry2 MHC IIhi cells
FIGURE 3. CX3CR1hi cells do not migrate during STM infection. MLNx CX3CR1+/GFP mice were infected with DinvG STM after pretreatment with the
antibiotic mixture. (A) Representative FACS plots of CX3CR1 expression are shown, classified as low, intermediate, or high, on SI LP DCs (middle plot)
and macrophages (right plot). The graph shows the percentage of DCs and macrophages with each level of CX3CR1 expression. (B) Frequency of intestinal
DCs and macrophages being CX3CR1lo/2 (circles), CX3CR1int (squares), and CX3CR1hi (triangles). (C) CX3CR1 expression within total MHC II+CD11c+
lymph DCs (left and central plots) and total live lymph cells (right plot). (D) Frequency of lymph DCs being CX3CR1lo/2 (circles), CX3CR1int (squares),
and CX3CR1hi (triangles). n = 4–6 per group, data pooled from two independent experiments.
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to identify any dominant STM-transporting DC population. Our
results showed that all DC populations were present in similar
proportions among both the mCherry+ and mCherry2 cells (Fig. 4B).
We calculated the ratio of mCherry+ over mCherry2 events and
compared them between MHC IIhi and MHC IIint cells, thus
demonstrating that DCs were the cells most frequently associated
with mCherry STM (Fig. 4C). We also identified an mCherry+
signal within the MHC IIint population, which we investigated
to characterize these populations (Fig. 4D). We observed that the
mCherry+ MHC IIint population is composed of two B cell pop-
ulations (B220+CD11b2 and B220+CD11b+) plus a third pop-
ulation mostly made up by B2202CD11b+Ly6G+ neutrophils.
(Fig. 4D, Supplemental Fig. 2).
To determine whether the lymph cells carried live bacteria, we
attempted to recover STM CFU from flow-sorted lymph cells
grown on selective culture medium. Thus, we infected MLNx
mice with conventional DAroA STM sorted up to 2.5 3 105 total
DCs and the three MHC IIint subsets. Sorted cells were then
plated on streptomycin-enriched LB agar to select STM colo-
nies (Fig. 4E). Interestingly, we only recovered viable DAroA
STM from DCs. To then identify whether any particular DC
subset carried STM, we flow-sorted and cultured each of the DC
subsets (Fig. 4F). We find that CD103+CD11b+ and CD103+CD11b2
cells carried most of the STM, but some colonies were cultured
from all DC subsets (Fig. 4G).
Taken together, our data indicate that although STM may be
associated with B cells and neutrophils in lymph, only DCs carry
viable STM.
A proportion of STM migrates by a cell-independent mechanism
Results above were obtained using attenuated auxotrophic STM
strains. To assess whether nonattenuated STM is also transported
by similar mechanisms, we performed the following experiments
with the SL1344 parent strain (12, 24, 25). As is common for
experiments with SL1344, mice were pretreated with a single oral
dose of 20 mg of streptomycin 24 h before oral infection to in-
crease the numbers of colonizing STM. By 96 hpi, streptomycin-
treated STM-infected animals had, as expected, experienced
significant weight loss compared with STM-infected animals
(Fig. 5A). To assess the extent of dissemination of STM in these
animals, we harvested spleens, MLN, and ILN and quantified
STM CFUs by homogenizing and plating tissue on streptomycin-
enriched LB agar. As expected, infected animals that were treated
with streptomycin yielded significantly higher CFUs in the MLN
than animals not pretreated with streptomycin. Similar to the
antibiotic mixture used above, streptomycin pretreatment did not
FIGURE 4. All DC subsets can carry viable STM. MLNx mice were infected with 13 108 mCherry AroA STM or AroA STM control after pretreatment
with an antibiotic mixture, and lymph was collected 48 hpi. (A) mCherry+ events were analyzed from among live lymph cells and subdivided based on their
MHC II expression. (B) DC subsets within mCherry2 MHC IIhi– and mCherry+ MHC IIhi–infected lymph. (C) Relative abundance comparison between
mCherry+ events in MHC IIhi and MHC IIint lymph fractions. (D) B220 and CD11b expression from mCherry2 and mCherry+ within MHC IIint cells. (E)
AroA STM recovery from sorted total DC, B1, B2, and neutrophil populations. (F) AroA STM recovery from sorted DC subsets. (G) AroA STM viable
colonies recovered per mouse from each lymph DC subset. Data representative of at least three independent experiments. ***p, 0.001, Wilcoxon matched
pairs signed-rank test.
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affect the frequency or numbers of macrophages and DCs in the
intestinal LP or MLN (Supplemental Fig. 3). Systemic spread of
STM was observed in streptomycin-pretreated mice, indicated
by their significantly higher CFU counts from spleen and ILNs
(Fig. 5B). The final stages of the dissemination to the spleen must
occur via the bloodstream, as the spleen lacks a lymphatic supply
(26, 27). To assess the as-yet-unknown contribution of intestinal
lymph to the transport of STM in this model, we first aimed to
identify the cells in the MLN that become STM infected. From our
data above, we predicted that migratory DCs in the MLN, which
express the highest levels of MHC II, would harbor the highest
numbers of STM. We therefore flow-sorted intestine-derived migra-
tory DCs (MHC IIhiCD11c+), MLN-resident DCs (MHC II+CD11c+),
B cells (B220+), and macrophages (CD64+) from MLN of infected
mice. Each of these purified populations was lysed with a deter-
gent solution and plated overnight. As expected, STM was re-
covered from migratory DCs, whereas MLN-resident DCs yielded
fewer CFUs (Fig. 5C). Interestingly, CD64+ macrophages in the
MLN carried the highest number of CFUs despite the fact that
they do not migrate in lymph (Fig. 3). Therefore, to understand
how lymph node–resident macrophages acquire STM, espe-
cially when so few DCs are actively carrying live bacteria, we
investigated whether STM may be traveling in lymph in a cell-
free form and being captured by macrophages upon reaching
the MLN. We tested this after pretreating animals with either
the antibiotic mixture or streptomycin treatment. MLNx mice
were pretreated with antibiotics and infected with SL1344
STM. Lymph was obtained by thoracic duct cannulation of
MLNx mice, as described above, and cells were separated
from the lymph supernatant by centrifugation. The cell pellet
and lymph supernatant were plated separately and CFUs
quantified. This revealed that, surprisingly, similar numbers of
STM were detected in the cell-associated and cell-free lymph
fractions (Fig. 5D). Taken together, our results demonstrate
that no macrophages travel in lymph, small numbers of viable
bacteria are carried by migratory lymph DCs, and STM also
travel in lymph independently of cells and are delivered to
macrophages and B cells in the MLN.
Discussion
The early immune response to STM infection and the role of
the MLN in limiting bacterial dissemination have been well
characterized (5, 9, 28). However, the involvement of the in-
testinal lymphatic drainage in bacterial migration from the
intestinal mucosa to the MLN, to our knowledge, has not previ-
ously been clearly described. In this study, we used attenuated
and nonattenuated STM to examine their effects on previously
reported STM-associated DC and macrophage populations. We
demonstrate that STM infection causes only subtle cellular dis-
ruptions in the days immediately postinfection. We then examined
associations with cell populations from the MLN and thoracic
duct lymph to understand how STM migrates to the MLN.
Our work reveals that although STM may be associated with
MHC IIint cells (B cells and neutrophils), viable bacteria are
only transported by DCs and, surprisingly, by an autonomous
route.
We initially demonstrated that the frequencies of DC pop-
ulations do not change, either in the intestinal LP or the MLN in
the 2 d after STM infection. Thus, the infection does not have
significant early effects on the overall patterns of DC migration.
We did observe, however, an increase in the frequency of mac-
rophages in the SI of antibiotic-treated infected mice (Figs. 1, 2).
FIGURE 5. STM dissemination to the MLN is only partially dependent on cell-mediated transport. C57BL/6 mice were pretreated with either 20 mg of
streptomycin (Strep) or PBS (control) followed by oral infection with 1.5 3 108 CFU of SL1344 STM after 24 h [(A and B) n = 4 mice per group, data
representative of two independent experiments]. Animals were weighed daily, and after 4 d, bacteria were recovered and quantified from spleen, MLN, and
ILN. (C) APC populations from MLN of antibiotic-treated infected mice (5 3 107 CFU) were sorted and plated in streptomycin-supplemented LB agar
48 hpi. CFUs were counted from migratory and MLN-resident DCs, B cells, and macrophages, and the total CFU per MLN were calculated (n = 3–5 mice
per group, data pooled from three independent experiments). (D) Cell-associated and cell-free STM was harvested from lymph and quantified either from
animals pretreated with an antibiotic mixture and administered 1 3 108 CFU of DinvG STM (filled circles) or from animals pretreated with 20 mg of
streptomycin and administered 5 3 107 CFU of SL1344 STM (open circles) (n = 2–4 mice per group, data representative of at least three experiments).
Error bars show SD. (A) **p , 0.01, ***p , 0.001, two-way ANOVA with multiple comparisons. (B) **p , 0.01, ***p , 0.001, one-way ANOVA.
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This may reflect an influx of proinflammatory cells to the infected
intestine. Although the colon and cecum are the prominent sites of
pathology during infection, the SI may be the initial site of bac-
terial colonization (5). This colonization likely leads to increased
monocyte infiltration, which then accumulate and develop into
CD64+ macrophages (29).
A pivotal feature that differentiates DCs from macrophages is
their ability to migrate to draining lymph nodes (14, 15). How-
ever, it has been reported that CX3CR1hi mononuclear phago-
cytes are induced to migrate in lymph after STM infection,
carrying bacteria to the MLN of infected mice (18). To charac-
terize these migrating cells, we performed thoracic duct cannu-
lation on STM-infected CX3CR1+/GFP reporter mice, using a
similar preinfection antibiotic treatment and STM strain as in the
previous report. We demonstrate in this paper that DCs, which can
express intermediate levels of CX3CR1 (15), were able to migrate
in intestinal lymph, whereas none of the lymph-migrating cells
expressed high levels of CX3CR1 or CD64. Thus, DCs, but not
macrophages, travel from the intestine to the MLN in the first 48 h
after STM infection.
To find which cells carry STM from the intestine to the MLN, we
used DaroA mCherry-expressing STM, which can be detected by
flow cytometry. We therefore collected the cells migrating in
lymph after STM-mCherry infection of antibiotic-treated mice
and quantified the frequencies of cells associated with mCherry+
fluorescent STM. We found the mCherry+ signal in lymph as-
sociated with all DC subsets. Interestingly, mCherry+ cells
were also found among MHC IIint lymph cells, including two
populations of B cells (B220+CD11b2 and B220+CD11b+) and
neutrophils. Although we have previously observed small num-
bers of neutrophils in samples of lymph from cannulated ani-
mals, it had not been possible to determine whether these cells
were from the lymph itself or from a tiny volume of contami-
nating blood. In this study, however, a considerable proportion
of the neutrophils are mCherry+ after mice have been orally in-
fected and before systemic STM are detectable; therefore, we
think they are likely to originate from the intestine and travel to
the MLN (26, 27).
To quantify live STM carried by each of the different mCherry+
cell types, we sorted and plated cells on selective medium. This
revealed that viable STM is carried exclusively by DCs. Although
slightly more STM was recovered from CD103+CD11b+ and
CD103+CD11b2 DCs, all DC populations have the ability to carry
viable bacteria. Calculations from these STM culture experi-
ments reveal that only approximately one in 47,000 DCs
carries viable bacteria. Thus, we sought to understand whether
there may be other routes by which viable bacteria reach the
MLN.
Strikingly, as well as observing that STM travels in lymph
in DCs, we found that only half of the STM in lymph are traveling
in cell-associated form. This autonomous migration of STM in
intestinal lymph could explain why we recover more STM CFUs
from MLN-resident macrophages and B cells than from MLN
migratory DCs. The STM-positive macrophages are likely to
be macrophages lining the subcapsular sinuses that are known
to bind extracellular pathogens from lymph (30, 31). As the
macrophages themselves do not migrate in lymph, the STM-
associated macrophages in the MLN may have acquired many
of the bacteria that arrive in the MLN via lymph in a cell-free
form (32). Finally, a recent report showed that mesenchymal
cell MyD88-dependent sensing of STM may contribute to its
systemic spread (33), thus highlighting the importance of the
MLN and its resident cells and raising new questions about the
potential functions of MLN.
Our data demonstrate that the migration of STM from the in-
testine to the MLN via lymph is more complex than previously
thought. We reveal that in lymph, viable STM is not only trans-
ported by DCs but also autonomously. On reaching the MLN, STM is
taken up by MLN-resident macrophages, DCs, and by some B cells.
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